CircoMax

Authorised

This medicine is authorised for use in the European Union

porcine circovirus vaccine (inactivated recombinant)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  CircoMax
• Active substance:
  recombinant chimeric porcine circovirus 1 containing the porcine circovirus 2a open reading frame 2 protein, inactivated,Recombinant chimeric porcine circovirus 1 containing the porcine circovirus 2b open reading frame 2 protein, inactivated
• International non-proprietary name (INN) or common name:
  porcine circovirus vaccine (inactivated recombinant)

Pharmacotherapeutic group

• Immunologicals for suidae
• Inactivated viral vaccines

Authorisation details

• EMA product number:
  EMEA/V/C/005185

Assessment history

Changes since initial authorisation of medicine

CVMP post-authorisation summary of positive for CircoMax

Adopted Reference Number: EMA/CVMP/452706/2023

Initial marketing authorisation documents

CVMP summary of positive opinion for CircoMax

Adopted Reference Number: EMA/CVMP/617167/2021